SCHEMBL687540

SCHEMBL687540

COc1ccc2cc([C@H](CC(=O)O)NC(=O)Nc3c(O)ccn(Cc4ccccc4Cl)c3=O)ccc2c1

nearest known ligand 0.48

Predicted protein targets (top 13)

geneUniProtsupporting neighboursconfidence
PTGER3 P43115 14/20 0.48
CTSA P10619 2/20 0.40
LCK P06239 1/20 0.39
ALDH1A1 P00352 2/20 0.39
KDM4E B2RXH2 1/20 0.39
MEN1 O00255 1/20 0.39
KMT2A Q03164 1/20 0.39
GCGR P47871 1/20 0.38
MAPT P10636 1/20 0.38
THRB P10828 1/20 0.38
HPGD P15428 1/20 0.38
NPSR1 Q6W5P4 1/20 0.38
RXFP1 Q9HBX9 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL688406 1.00 PTGER3 (0.48) PTGER3CTSALCKALDH1A1KDM4E
SCHEMBL687117 0.93 PTGER3 (0.52) PTGER3ALDH1A1KDM4EMEN1KMT2A
SCHEMBL687524 0.93 PTGER3 (0.45) PTGER3CTSALCKALDH1A1KDM4E
SCHEMBL687411 0.92 PTGER3 (0.42) PTGER3ALDH1A1KDM4E
SCHEMBL688236 0.90 PTGER3 (0.47) PTGER3LCKALDH1A1KDM4EMAPT
SCHEMBL687904 0.89 PTGER3 (0.47) PTGER3CTSAALDH1A1KMT2AMAPT
SCHEMBL686938 0.88 PTGER3 (0.47) PTGER3CTSALCKALDH1A1GCGR
SCHEMBL687114 0.88 PTGER3 (0.45) PTGER3CTSAALDH1A1MAPT
SCHEMBL688250 0.88 PTGER3 (0.45) PTGER3CTSAALDH1A1MAPTRXFP1
SCHEMBL687672 0.87 CYP26A1 (0.43) PTGER3ALDH1A1KDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1203766-B1 Carboxylic acid derivatives that inhibit the binding of integrins to their receptors ENCYSIVE PHARMACEUTICALS INC (US) 2012-02-29 EP disclosed
EP-1203766-A2 Carboxylic acid derivatives that inhibit the binding of integrins to their receptors TEXAS BIOTECHNOLOGY CORPORATION (US) 2002-05-08 EP disclosed